Admission Date:  [**2118-5-19**]              Discharge Date:   [**2118-5-24**]  Date of Birth:  [**2037-8-1**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 30**] Chief Complaint: BRBPR  Major Surgical or Invasive Procedure: EGD [**2118-5-19**] Colonoscopy [**2118-5-23**] Capsule endoscopy [**Date range (3) 103721**]   History of Present Illness: 80yoM with CAD s/p DES to RCA and LCx [**2110**], likely instent thrombosis [**5-/2118**] in setting of stopping ASA/Plavix; also with HTN/HL/DM, PVD, CKD baseline Cr 1.4-1.7 who presented to ED after having BRBPR, dizziness, and SOB walking upstairs tonight at 5pm.
EMS noted pt to have SBP 80, PIV was placed and pt given IVF's.
Of note pt was recently admitted [**5-12**] to [**5-13**] after having stopped Plavix and ASA for upcoming spinal stenosis surgery, had code STEMI inferolateral leads, Plavix 600 mg loaded, and was taken to cath lab which showed probable instent thrombosis of LCx stent that had resolved with antithrombotics.
He was given Integrillin x12 hrs and restarted on daily ASA 325 and Plavix 75.
Noted to have slow 4:1 Aflutter with CHADS2 of 3, but deferred Coumadin to outpt Cards given he was on dual antiplatelets already.
Past Medical History: CAD s/p RCA and LCx PCI [**2110**] h/o exercise induced SVT CRI (baseline 1.7-2.3) PVD ([**2113-5-4**], revascularization of B/L iliacs) [**7-9**] 60% lesion REIA 70% lesion [**Female First Name (un) 7195**] s/p stents (5) LCIA s/p stent RCIA DJD GERD T2DM HTN Hyperlipidemia s/p excision of melanoma Gout Ulcerative Colitis (not active)  Social History: Married, with children and is a CPA.
DISCHARGE EXAM: VS:  97.5, 128/58, 73, 18, 95% RA GENERAL:  awake, alert, resting comfortably, NAD HEENT:  sclera anicteric, MMM, OP clear NECK:  supple, JVP 7-8 cm CARDIAC:  RRR, no r/m/g LUNGS:  bibasilar crackles, no wheezing or rhonchi, good air movement bilaterally, respirations unlabored, no accessory muscle use ABDOMEN: bowel sounds present, soft, NT/ND, no guarding or rebound tenderness EXTREMITIES: warm, well-perfused, DP pulses 2+, no edema, right thigh slightly tender to palpation in lateral area just above knee, no appreciable erythema, edema, or ecchymosis   Pertinent Results: ADMISSION LABS: [**2118-5-19**] 04:57PM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-1+ MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-1+ SCHISTOCY-OCCASIONAL BURR-1+ [**2118-5-19**] 04:57PM   NEUTS-85* BANDS-0 LYMPHS-5* MONOS-9 EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-1* [**2118-5-19**] 04:57PM   WBC-17.8*# RBC-3.26* HGB-9.0* HCT-29.7* MCV-91 MCH-27.6 MCHC-30.3* RDW-14.8 [**2118-5-19**] 04:57PM   URIC ACID-8.8* [**2118-5-19**] 04:57PM   UREA N-84* CREAT-2.7*# SODIUM-142 POTASSIUM-5.1 CHLORIDE-107 [**2118-5-19**] 04:57PM   GLUCOSE-204* [**2118-5-19**] 07:40PM   PT-13.4 PTT-24.1 INR(PT)-1.1 [**2118-5-19**] 07:40PM   cTropnT-0.03* [**2118-5-19**] 11:39PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2118-5-19**] 11:39PM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.014  OTHER PERTINENT LABS: [**2118-5-22**] 03:56AM BLOOD ALT-25 AST-16 AlkPhos-55 TotBili-0.2 [**2118-5-19**] 07:40PM BLOOD cTropnT-0.03* [**2118-5-19**] 11:43PM BLOOD CK-MB-3 cTropnT-0.03* [**2118-5-20**] 05:33AM BLOOD CK-MB-3 cTropnT-0.03* [**2118-5-20**] 12:41PM BLOOD CK-MB-3 cTropnT-0.02* [**2118-5-19**] 11:43PM BLOOD CK(CPK)-43* [**2118-5-20**] 05:33AM BLOOD CK(CPK)-32* [**2118-5-20**] 12:41PM BLOOD CK(CPK)-28*  DISCHARGE LABS: [**2118-5-24**] 07:10AM BLOOD WBC-12.1* RBC-3.40* Hgb-9.6* Hct-29.5* MCV-87 MCH-28.2 MCHC-32.4 RDW-14.6 Plt Ct-272 [**2118-5-24**] 07:10AM BLOOD Neuts-86* Bands-0 Lymphs-3* Monos-7 Eos-2 Baso-0 Atyps-0 Metas-0 Myelos-2* [**2118-5-24**] 07:10AM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-NORMAL Polychr-OCCASIONAL Ovalocy-OCCASIONAL Schisto-OCCASIONAL Tear Dr[**Last Name (STitle) 833**] [**2118-5-24**] 07:10AM BLOOD Glucose-217* UreaN-25* Creat-1.5* Na-141 K-4.2 Cl-106 HCO3-26 AnGap-13 [**2118-5-24**] 07:10AM BLOOD Calcium-8.3* Phos-2.4* Mg-1.7  MICROBIOLOGY: Urine culture [**2118-5-19**]: <10,000 organisms/ml.
Residual fluid and secretions at the antrum.
instent thrombosis treated with antithrombotics and discharged on ASA/Plavix (no Coumadin), CKD, PVD, and DM/HTN/HL who presented with BRBPR, Hct drop, leukocytosis with bandemia,  and [**Last Name (un) **].
Acute Blood Loss Anemia:  Patient was started on PPI gtt and Octreotide gtt.
Diverticulosis seen on prior colonoscopy in [**2115**]; and initially was felt current GIB may be diverticular bleed exacerbated by daily ASA/Plavix.
Plavix was held but ASA was continued after discussion with outpatient cardiologist, given high risk of in-stent thrombosis.
Per discussion with cardiology prior to discharge, patient's ASA dose decreased to 81mg daily and Plavix restarted for at least 2 additional weeks.
CAD/In-stent thrombosis: s/p RCA and LCx PCI [**2110**].
Patient recently admitted to CCU with STEMI in setting of holding ASA/Plavix prior to planned spinal fusion surgery, ?
Patient had been discharged on lifelong ASA 325mg daily, and plavix for at least 4-6 weeks, though presented this admission with BRBPR as above.
Plavix was held and ASA was continued in the setting of GIB after discussion with his outpatient cardiologist, as mentioned above.
Home antihypertensives were held in setting of acute GIB, though restarted on discharge day as patient remained hemodynamically stable.
Patient discharged on aspirin, plavix, statin, beta blocker, and ACE inhibitor.
Has a history of gout, on Allopurinol and Colchicine in past at home.
Held Allopurinol in the setting of ARF on initial presentation but pain improved in-house.
Patient discharged back on Allopurinol given improvement in renal function.
[**Last Name (un) **] was felt to be pre-renal in setting of acute blood loss, and resolved with IVF and blood product administration.
#) DJD: Patient received acetaminophen prn pain.
Patient was on diabetic diet, FSBS monitored, and he was on insulin sliding scale.
#) HTN: BP generally well controlled off anti-hypertensive meds, which were held in setting of recent GI bleeding.
LABS/STUDIES PENDING AT TIME OF DISCHARGE: Blood cultures [**2118-5-19**]  ISSUES REQUIRING FOLLOW-UP: -Patient will follow-up with PCP, [**Name10 (NameIs) **], and cardiology -Patient was a FULL code during this admission -Should continue on aspirin 81 mg daily and plavix 75mg daily for now, and follow-up with cardiology -Should have repeat Hct check at PCP [**Last Name (NamePattern4) 702**]  Medications on Admission: Aspirin 325mg daily Plavix 75mg daily Atorvastatin 80mg daily Omeprazole 20mg daily Lisinopril 10mg daily Atenolol 50mg daily Amlodipine 5mg daily Glipizide 5mg daily Allopurinol 100mg daily SL NTG PRN Multivitamin daily  Discharge Medications: 1. atorvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
2. omeprazole 40 mg Capsule, Delayed Release(E.C.)
)(s)* Refills:*2* 3. lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day.
4. atenolol 50 mg Tablet Sig: One (1) Tablet PO once a day.
5. amlodipine 10 mg Tablet Sig: 0.5 Tablet PO once a day.
6. glipizide 5 mg Tablet Sig: One (1) Tablet PO once a day.
7. allopurinol 100 mg Tablet Sig: One (1) Tablet PO once a day.
8. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) tab Sublingual every 5 minutes, may take up to 3 times as needed for chest pain.
9. multivitamin     Tablet Sig: One (1) Tablet PO once a day.
10. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO once a day.
You received a blood transfusion, and your blood counts stabilized.
Given the bleeding, your Aspirin and Plavix were initially held.
The Aspirin was restarted, and per disucssion with the Gastroenterology and Cardiology, it was advised that you continue taking Aspirin for lifelong and Plavix for at least another 2 weeks.
The Aspirin can be decreased to 81mg daily.
DECREASED Aspirin to 81mg daily  We did not make any other changes to your medications.
Please continue to take them as you have been doing, including Plavix and lower dose Aspirin.
Department: [**Hospital **] MEDICAL GROUP When: MONDAY [**2118-5-30**] at 11:15 AM  Department: [**Last Name (un) 12214**] [**Doctor Last Name **] MED GRP When: TUESDAY [**2118-5-31**] at 1 PM With: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1013**], MD [**Telephone/Fax (1) 5068**] Building: [**Location (un) **] ([**Location (un) 86**], MA) [**Location (un) **] Campus: OFF CAMPUS     Best Parking: On Street Parking  Department: GASTROENTEROLOGY When: MONDAY [**2118-6-27**] at 3:15 PM With: [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Last Name (NamePattern1) **], M.D.
